1
项与 Sialyl Lewisa-KLH conjugate vaccine(NCI) 相关的临床试验Pilot Study of Immunization of High Risk Breast Cancer Patients With a Sialyl Lewisª -Keyhole Limpet Hemocyanin Conjugate Plus the Immunological Adjuvant QS-21
RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. Giving vaccine therapy together with QS21 may cause a stronger immune response and kill more tumor cells.
PURPOSE: This clinical trial is studying the side effects and how well giving vaccine therapy together with QS21 works in treating patients with metastatic breast cancer.
100 项与 Sialyl Lewisa-KLH conjugate vaccine(NCI) 相关的临床结果
100 项与 Sialyl Lewisa-KLH conjugate vaccine(NCI) 相关的转化医学
100 项与 Sialyl Lewisa-KLH conjugate vaccine(NCI) 相关的专利(医药)
100 项与 Sialyl Lewisa-KLH conjugate vaccine(NCI) 相关的药物交易